The Latest Protein Engineering Industry Statistics Explained
The Global Protein Engineering Market size was assessed at USD 1.1 billion in 2020.
The statistic indicates that the Global Protein Engineering Market was valued at USD 1.1 billion in 2020. This figure represents the total market value of protein engineering services, products, and technologies worldwide during that year. Protein engineering involves the modification and design of proteins to develop new therapeutic treatments, diagnostics, industrial enzymes, and other biotechnological applications. The market size of USD 1.1 billion highlights the significant economic activity and investment in the protein engineering sector, reflecting the growing demand for advanced protein technologies and the potential for further expansion and innovation within the industry.
The Protein Engineering Market is expected to register a CAGR of 14.3% from 2021 to 2028.
The statistic “The Protein Engineering Market is expected to register a CAGR of 14.3% from 2021 to 2028” indicates the projected Compound Annual Growth Rate (CAGR) for the protein engineering market over the specified period. A CAGR of 14.3% suggests a robust growth trajectory, with the market value expected to increase at an average annual rate of 14.3% during the timeframe. This statistic reflects a positive outlook for the protein engineering industry, indicating increasing demand, advancements in technologies, and potential opportunities for innovation and investment in this sector over the coming years.
North America dominated the global protein engineering market with a share of 45.4% in 2020.
The statistic stating that North America dominated the global protein engineering market with a share of 45.4% in 2020 indicates that nearly half of the market for protein engineering technologies and services was captured by North American companies, institutions, and research efforts. This high market share suggests that North America is a significant hub for innovation and developments in the field of protein engineering. Factors contributing to this dominance may include a strong research and development ecosystem, robust industry-academic collaborations, access to cutting-edge technologies, and a skilled workforce. The statistic also implies that North America is likely to continue playing a leading role in shaping the future of protein engineering advancements and applications on a global scale.
Monoclonal antibodies contributed to a 44.4% share in the Protein Engineering market in 2020.
The statistic “Monoclonal antibodies contributed to a 44.4% share in the Protein Engineering market in 2020” indicates that monoclonal antibodies accounted for nearly half of the market for protein engineering in the year 2020. This suggests that monoclonal antibodies were a significant player in the industry, demonstrating their importance and widespread use within the field of protein engineering during that time. This statistic highlights the popularity and impact of monoclonal antibodies in driving advancements and innovations within the protein engineering sector.
Pharmaceutical and Biotech Companies held the leading position in the protein engineering market with over 30% share in 2020.
This statistic indicates that Pharmaceutical and Biotech Companies held a dominant position within the protein engineering market in 2020, capturing more than 30% of the market share. This suggests that these types of companies were the primary contributors to advancements and innovations in protein engineering during that year. Their leading position signifies their significant investment in research and development, as well as their focus on developing new technologies and therapies related to proteins. This high market share also suggests a competitive advantage for Pharmaceutical and Biotech Companies in the protein engineering sector, positioning them as key players shaping the industry’s trajectory and driving its growth and development.
The protein engineering market size is expected to reach upwards of USD 4.77 billion by 2027.
Based on current market trends and forecasts, the protein engineering market is projected to experience substantial growth over the coming years, with expectations that its size will surpass USD 4.77 billion by the year 2027. This statistic suggests a significant increase in the demand for protein engineering services and products, driven by factors such as advancements in biotechnology, increasing investment in research and development, and the growing importance of protein-based therapeutics and biologics. The projected market size indicates a promising outlook for the protein engineering industry, highlighting its potential for continued expansion and innovation in the coming years.
The demand for protein engineering is anticipated to grow due to increased availability of protein structure prediction using bioinformatics tools.
The statistic suggests that there is an expected rise in the demand for protein engineering services. This anticipated growth is attributed to the increasing accessibility of advanced bioinformatics tools that aid in predicting protein structures. As more efficient and accurate bioinformatics tools become available, researchers and industries in fields such as medicine, biotechnology, and agriculture are likely to utilize protein engineering to design or modify proteins for various applications. The ability to predict protein structures using these tools is crucial for understanding the functions and behaviors of proteins, which in turn can drive innovation and the development of novel products and technologies in the protein engineering sector.
Asia Pacific is expected to grow at the highest CAGR among other regions in the protein engineering market, predicted to be 15.4% from 2021 to 2028.
The statistic indicates that the Asia Pacific region is anticipated to exhibit the highest Compound Annual Growth Rate (CAGR) in the protein engineering market compared to other regions from 2021 to 2028, with a projected growth rate of 15.4%. This suggests that protein engineering technologies and applications are likely to experience significant growth and adoption within the Asia Pacific region during this period. Factors such as increasing research and development activities, growing investments in biotechnology and pharmaceutical sectors, and rising demand for personalized medicine and biologics in countries like China, Japan, and India may contribute to the robust growth of the protein engineering market in the Asia Pacific region.
The instrumentation segment in protein engineering is expected to grow at a CAGR of 14% from 2021 to 2028.
This statistic implies that the instrumentation sector within the field of protein engineering is projected to experience a Compound Annual Growth Rate (CAGR) of 14% from the year 2021 to 2028. This forecast suggests a significant and steady increase in demand for instrumentation tools and technologies used in protein engineering applications over the specified time frame. Factors contributing to this growth may include advancements in technology, increased research and development activities, as well as rising interest and investment in the field of protein engineering. The projection of a CAGR of 14% indicates a positive outlook for the instrumentation segment within the protein engineering industry, signaling potential opportunities for innovation and market expansion in the coming years.
The reagents segment in protein engineering is anticipated to witness the fastest growth and is estimated to reach USD 0.8 billion by 2028.
The statement suggests that within the field of protein engineering, the reagents segment is expected to experience rapid growth, outpacing other segments in terms of revenue generation. This growth is projected to culminate in the reagents segment reaching a value of USD 0.8 billion by the year 2028. This forecast indicates a strong demand for reagents used in protein engineering processes, such as enzymes, antibodies, and other biological molecules, pointing towards potential advancements and innovations within the field. The anticipated growth in the reagents segment highlights its importance in driving the overall expansion and progress of the protein engineering industry.
The predicted future market size of academic research institutes in protein engineering is expected to reach USD 0.9 Bn by 2028.
The statistic indicates that the predicted future market size of academic research institutes specializing in protein engineering is projected to grow to USD 0.9 billion by the year 2028. This suggests a substantial increase in investment and funding within this sector over the upcoming years, reflecting a growing interest and recognition of the importance of protein engineering in various fields such as biotechnology, pharmaceuticals, and healthcare. The anticipated expansion in market size points towards a promising outlook for academic research institutes engaged in protein engineering, indicating potential advancements, innovations, and contributions to the scientific community and industry as a whole.
By 2028, the estimated market size for contract research organizations in protein engineering is expected to reach USD 1.5 billion.
The statistic indicates that the market size for contract research organizations in protein engineering is projected to grow significantly by 2028, reaching an estimated value of USD 1.5 billion. This suggests a positive and increasing demand for services provided by contract research organizations in the field of protein engineering over the next several years. Such growth may be driven by factors such as advancements in biotechnology and pharmaceutical industries, increasing research and development activities, and a growing need for specialized expertise in protein engineering. This statistic highlights the potential opportunities for businesses operating in this sector and underscores the importance of investing in research and development capabilities to capitalize on this anticipated market expansion.
In 2020, the monoclonal antibodies market dominated the global protein engineering market, accounting for 44.4% of the total market’s revenue.
In 2020, the dominance of the monoclonal antibodies market within the global protein engineering market was evident, with this segment representing a substantial 44.4% share of the total market’s revenue. This statistic indicates that monoclonal antibodies were a major driving force in the protein engineering industry during that year, outperforming other segments. The significant market share held by monoclonal antibodies suggests a high demand for these protein-engineered products, likely driven by their wide range of applications in various therapeutic areas such as oncology, autoimmune diseases, and infectious diseases. This market dominance underscores the importance and popularity of monoclonal antibodies in the field of protein engineering in 2020.
In 2020, Pharmaceutical & Biotech Companies accounted for the largest share in the applications segment of the protein engineering market.
In 2020, the statistic shows that Pharmaceutical & Biotech Companies held the dominant position within the applications segment of the protein engineering market. This suggests that these companies were the primary users of protein engineering technologies for various purposes such as drug discovery, development of biologics, protein therapeutics, and other biotechnology applications. The significant share held by Pharmaceutical & Biotech Companies indicates their reliance on protein engineering to innovate and advance their research and development efforts, reflecting the importance and impact of protein engineering within the life sciences industry.
The emergence of proteomics and system biology are expected to offer potential growth opportunities for protein engineering market.
The statistic suggests that the fields of proteomics and systems biology are anticipated to provide promising prospects for the protein engineering market. Proteomics is the study of proteins and their functions within biological systems, while systems biology is the study of complex interactions within biological systems. These emerging fields offer new insights into protein structures, interactions, and functions, which can be leveraged in the development of novel protein engineering strategies. By integrating knowledge from proteomics and systems biology, researchers and companies involved in the protein engineering market can enhance their understanding of protein behavior and design more advanced and efficient proteins for various applications, leading to potential growth opportunities within the industry.
The applications segment of Protein Engineering Market in Asia Pacific is estimated to witness the fastest growth rate of 15.6% from 2021 to 2028.
The statistic states that the applications segment of the Protein Engineering Market in Asia Pacific region is projected to experience a rapid growth rate of 15.6% between the years 2021 and 2028. This suggests a high level of demand and adoption of protein engineering technologies and products within various industries such as biopharmaceuticals, food and beverages, and agriculture. The substantial growth rate indicates a strong market potential in the region, highlighting the increasing significance of protein engineering in driving innovation and advancements in product development and research. This statistic underscores the opportunities for companies operating in the protein engineering sector to capitalize on the expanding market landscape in Asia Pacific.
Japan was the largest regional market for protein engineering in 2020.
The statistic “Japan was the largest regional market for protein engineering in 2020” indicates that among all the regions worldwide, Japan demonstrated the highest market demand and consumption for protein engineering products and services in the year 2020. This could imply that Japan’s biotech and pharmaceutical industries invested significantly in protein engineering research and development, leading to a surge in market growth and adoption of protein engineering technologies within the country. Factors contributing to Japan’s leadership in this market could include a strong academic and research infrastructure, innovative companies focused on biotechnology, and favorable government policies supporting the bioengineering sector.
Europe, after North America, holds the second largest market for protein engineering, amounting to a third of the global revenue.
The statistic indicates that Europe is the second-largest market for protein engineering after North America, comprising about one-third of the total global revenue generated from this sector. This suggests that protein engineering research and technology are significant in Europe, contributing substantially to the industry’s overall revenue. The statistic highlights Europe’s prominent position in the protein engineering market, showcasing the region’s strong focus on and investment in this area of biotechnology and life sciences. It implies that there is considerable potential for growth and innovation in the protein engineering sector in Europe, positioning the region as a key player in advancing this field globally.
An important driving factor for the protein engineering market is the rise in prevalence of protein-deficiency syndromes among geriatric populations.
The statistic highlights the significance of the rise in prevalence of protein-deficiency syndromes among geriatric populations as a key driving factor for the protein engineering market. With an aging population worldwide, the incidence of protein-deficiency syndromes such as malnutrition and sarcopenia is increasing among older individuals. This trend necessitates the development of novel protein engineering solutions to address the specific nutritional needs and health challenges faced by the elderly. As a result, there is a growing demand for innovative protein-based interventions and therapeutics that can help manage and prevent protein-deficiency syndromes in geriatric populations, thereby driving the growth of the protein engineering market.
Increased demand for therapeutic proteins in the management of chronic diseases will significantly drive the protein engineering market.
This statistic suggests that there is a growing trend towards using therapeutic proteins for the treatment of chronic diseases, and this is expected to have a substantial impact on the protein engineering market. Therapeutic proteins are molecules that can be designed and engineered to target specific disease pathways, offering potential benefits for managing chronic conditions effectively. As the demand for these innovative treatments continues to rise due to the increasing prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, the protein engineering market is predicted to experience significant growth to meet the expanding therapeutic protein needs. This trend highlights the potential opportunities for advancements in protein engineering technologies and the development of new and improved therapeutic proteins to address the challenges associated with chronic diseases.
References
0. – https://www.www.alliedmarketresearch.com
1. – https://www.www.grandviewresearch.com
2. – https://www.www.bccresearch.com
3. – https://www.www.reportsanddata.com
4. – https://www.cerillion.com
5. – https://www.www.marketdataforecast.com
